Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Traitor-virus-guided discovery of antiviral factors

Project description

An innovative approach to uncover the spectrum of cell antiviral mechanisms

The EU-funded Traitor-Viruses project proposes a highly innovative approach to developing specific genome-wide identification of antiviral mechanisms. The researchers will construct libraries of replication-competent human immunodeficiency virus-1 that express guide RNAs which potentially can inactivate every human gene in Caspase-9 expressing cells. Library variants expressing guide RNAs inactivating antiviral genes will be selected by passaging and identified by next-generation sequencing. Using different viral backbones, the researchers will be able to discover the defence factors against human and animal viruses. The project will determine the spectrum of innate antiviral factors that can be used in preventive and therapeutic approaches.

Objective

Viruses may seem smart since they rapidly develop new skills to spread in humans. However, they are actually just masters of trial and error. Their short generation time, enormous reproduction and high variability allows viruses to try countless variations. A few of these will enhance viral spread and, in the worst case, enable viral pandemics. It is conceivable that viruses evolve to counteract those defence mechanisms that would otherwise be most effective against them. Usually, it is hard to assess why specific changes are advantageous. This is especially true for adaptations enabling viral pathogens to counteract innate antiviral factors because these cellular proteins and their viral antagonists are numerous and highly versatile. Here, I propose to combine the advantages of the revolutionary CRISPR/Cas9 technology with the enormous adaptive power of viruses to develop a novel approach allowing robust, specific and genome-wide unmasking of antiviral mechanisms. In principle, we will equip HIV-1 with genetic scissors to convert them into traitor viruses revealing their cellular opponents. To achieve this, we will generate libraries of replication-competent HIV-1 constructs expressing guide RNAs as genetic tools with the potential to inactivate every human gene in Cas9 expressing cells. Virus variants expressing guide RNAs eliminating antiviral genes will be selected by in vitro passaging and identified by next generation sequencing. Utilization of different viral backbones will allow the discovery of key defence factors against viral zoonoses and spread in humans. Finally, we will determine the antiviral spectrum and inducibility of innate antiviral factors to identify vulnerabilities of viral pathogens that can be exploited in preventive and therapeutic approaches. The project will establish and apply an innovative, highly versatile approach to uncover our antiviral defence mechanisms with the ultimate goal is to achieve better control of viral pathogens.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2021-ADG

See all projects funded under this call

Host institution

UNIVERSITAET ULM
Net EU contribution
€ 2 339 875,00
Address
HELMHOLTZSTRASSE 16
89081 Ulm
Germany
Region
Baden-Württemberg Tübingen Ulm, Stadtkreis
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 2 339 875,00

Beneficiaries (1)